“Efficacy and safety of regorafenib versus dinutuximab with chemotherapy in Chinese children with neuroblastoma” (2019) Bangladesh Journal of Pharmacology, 14(1), pp. 32–35. doi:10.3329/bjp.v14i1.38807.